Good morning! Welcome back to Queen Street Analytics' weekly roundup of regulatory developments, legislative discussions, political announcements and other government-related news in biotech, pharmaceutical manufacturing, drug distribution and pricing, the life sciences and medical research.

Every Monday, we break down the most important updates in this space in under five minutes.

Start Date: 2025-04-06
End Date: 2025-04-12

Top Headlines

Main Stories

UBC's New Biomedical Engineering Building

On April 8, the University of British Columbia inaugurated its Gordon B. Shrum Building, a dedicated facility for biomedical engineering. The building aims to unite researchers, students, and industry partners in advancing medical devices and AI-driven diagnostics. Funded by the Government of B.C. and private donors, the facility supports the province's growing life sciences sector and prepares students for careers through hands-on training.

Sources: Provincial Announcement: news.gov.bc.ca

Eastern Summit 2025: Montreal's Revitalization

The Government of Quebec reviewed progress in East Montreal, investing $5.3 million in biotech firm ExCellThera for blood cancer treatments and $40 million in public transport enhancements. These efforts reflect the government's dedication to transforming East Montreal into a thriving economic hub through targeted financial support across various sectors, including culture, community, and tourism.

Sources: Provincial Announcement: www.quebec.ca

MP Larry Brock Advocates Drug-Free Treatment Funding

Larry Brock emphasized the need for funding lifesaving treatments to aid drug-free recovery, calling for increased support in this area.

Sources: Social Media: x.com

Don Davies on Pharmacare Policy

MP Don Davies announced the NDP's plan for full public pharmacare, focusing on essential medicines.

Sources: Social Media: x.com

What We're Reading This Week

• PHARMACEUTICAL COMPANIES: Overview of developments in the pharmaceutical sector.
• Quantum BioPharma Licensee Partnership: Details on Celly Nutrition's expansion with AATAC.
• BioClick Enzyme Engineering Launch: eXoZymes introduces BioClick with NIH grant support.
• Influenza Clinical Trials: Updates on influenza trials and approvals.
• Chronic Hepatitis B Trials: Progress in Chronic Hepatitis B trials.
• Parsons Biodefense Contract: Parsons secures $24 million biodefense contract.
• Daré Bioscience Strategy: Daré Bioscience to present expanded strategy.